Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0000899243-22-009074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | KYMR | Caughey Elaine | Chief Business Off | A - Grant | $0.00 | +7,000 | 7,000 | New | $0 |
| D | 2022-03-03 | 2022-03-01 | KYMR | Caughey Elaine | Chief Business Off | A - Grant | $0.00 | +41.0K | 41.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | A | A | 7,000 | $0.00 | 7,000 | D | — | — | (F1) Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in three equal annual installments following March 1, 2022, subject to the reporting person's continued employment through each vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | A | A | 41,000 | $0.00 | 41,000 | D | $38.53 · — to 2032-02-29 | 41,000 Common Stock | (F2) The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2022, subject to the reporting person's continued employment through each vesting date. |